Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer’s model mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer’s model mice ; volume:14 ; number:1 ; day:18 ; month:1 ; year:2024 ; pages:1-10 ; date:12.2024
Translational Psychiatry ; 14, Heft 1 (18.1.2024), 1-10, 12.2024
- Urheber
-
Cho, So Yeon
Kim, Eun Woo
Park, Soo Jin
Phillips, Benjamin U.
Jeong, Jihyeon
Kim, Hyunjeong
Heath, Christopher J.
Kim, Daehwan
Jang, Yurim
López-Cruz, Laura
Saksida, Lisa M.
Bussey, Timothy J.
Lee, Do Yup
Kim, Eosu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41398-024-02755-9
- URN
-
urn:nbn:de:101:1-2024033110301673053198
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cho, So Yeon
- Kim, Eun Woo
- Park, Soo Jin
- Phillips, Benjamin U.
- Jeong, Jihyeon
- Kim, Hyunjeong
- Heath, Christopher J.
- Kim, Daehwan
- Jang, Yurim
- López-Cruz, Laura
- Saksida, Lisa M.
- Bussey, Timothy J.
- Lee, Do Yup
- Kim, Eosu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Single-cell-led drug repurposing for Alzheimer’s disease
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Repurposing dapagliflozin for Alzheimer's disease: a mechanistic exploration
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data
Repurposing beta-3 adrenergic receptor agonists for Alzheimer’s disease: beneficial effects in a mouse model
Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer’s disease with real-world clinical validation
Disruption of specific GDNF receptor subtype signaling impairs cortical neuronal survival in Alzheimer’s brains
Author Correction: Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes
Single-cell-led drug repurposing for Alzheimer’s disease
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Repurposing dapagliflozin for Alzheimer's disease: a mechanistic exploration
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data
Repurposing beta-3 adrenergic receptor agonists for Alzheimer’s disease: beneficial effects in a mouse model
Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer’s disease with real-world clinical validation
Disruption of specific GDNF receptor subtype signaling impairs cortical neuronal survival in Alzheimer’s brains
Author Correction: Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes
Single-cell-led drug repurposing for Alzheimer’s disease
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Repurposing dapagliflozin for Alzheimer's disease: a mechanistic exploration
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data
Repurposing beta-3 adrenergic receptor agonists for Alzheimer’s disease: beneficial effects in a mouse model
Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer’s disease with real-world clinical validation
Disruption of specific GDNF receptor subtype signaling impairs cortical neuronal survival in Alzheimer’s brains
Author Correction: Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models